Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Knoll Pharmaceutical v. TEVA Pharmaceuticals (N.D. Ill. )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Knoll Pharmaceutical v. TEVA Pharmaceuticals
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Knoll Pharmaceutical v. TEVA Pharmaceuticals (N.D. Ill. )

Date Filed Document No. Description Snippet Link To Document
2002-09-12 186 infringement of United States Patent Nurnber 4,587,252 (“the ‘252 patent”). Teva has filed, pursuant to… of patent infringement For the reasons that follow, Teva’s motion for summary judgment of patent invalidity… States Patent and Trademark Office (“PTO”) the application which resulted in the ‘252 patent. (Def.’s… is used in Claims 1 and 2 of the ‘252 patent. The ‘252 patent claims: l. A process for treating pain…management in 1984 when the ‘252 patent application was filed. A patent is presumed valid. 35 U.S.C. § External link to document
2002-12-09 218 Judgrnent of Patent Invalidity, arguing that United States Patent No. 4,587,252 (“the ‘252 patent”) was anticipated…that the ‘252 patent was not anticipated by the Upjohn Applicationl and that the ‘252 patent was not obvious…. ’s (“Teva”), Motion for Surnrnary Judgment of Patent Invalidity. For the reasons that follow, Plaintiffs…Reconsideration is appropriate when “the Court has patently misunderstood a party, or has made a decision …anticipated by a European patent application by the Upjohn Company filed on June 25, 1982 (“the Upjohn External link to document
2001-08-21 24 has infringed on United States Patent NO. 4,587, 252 (the “252 Patent”), Which is held by Plaintiff …the 252 Patent because it seeks “FDA approval to engage, prior to the expiration of the 252 Patent, in the…Partnership (“Arnold”), filed a one-count Complaint for patent infringement against Defendant TEVA Pharmaceuticals…Which Plaintiffs allege is covered by the “25 2 Patent.” ( 12). Plaintiff`s further allege that…and/or use of the invention as claimed in the 252 Patent.” (Cornpl. 1] 15). TEVA filed its “Answer, Af` External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.